Hyperbilirubinemia in the early phase after allogeneic HSCT: Prognostic significance of the alkaline phosphatase/total bilirubin ratio

Bone Marrow Transplantation

Volumn 48, Issue 1, 2013, Pages 94-98

  Ashizawa, M ^a   Oshima, K ^a   Wada, H ^a   Ishihara, Y ^a   Kawamura, K ^a   Sakamoto, K ^a   Sato, M ^a   Terasako, K ^a   Machishima, T ^a   Kimura, S ^a   Kikuchi, M ^a   Nakasone, H ^a   Okuda, S ^a   Kako, S ^a   Kanda, J ^a   Yamazaki, R ^a   Tanihara, A ^a   Nishida, J ^a   Kanda, Y ^a  

^a JICHI MEDICAL UNIVERSITY   (Japan)

Author keywords

Alkaline phosphatase; HSCT; Hyperbilirubinemia; Total bilirubin

Indexed keywords

ALKALINE PHOSPHATASE; BILIRUBIN; CYCLOSPORIN A; METHOTREXATE; TACROLIMUS;

ACUTE GRAFT VERSUS HOST DISEASE; ADOLESCENT; ADULT; AGED; ALKALINE PHOSPHATASE BLOOD LEVEL; ALKALINE PHOSPHATASE TOTAL BILIRUBIN RATIO; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ANALYTICAL PARAMETERS; ARTICLE; BILIRUBIN BLOOD LEVEL; CLINICAL EFFECTIVENESS; CONTINUOUS INFUSION; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE CLASSIFICATION; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; FEMALE; HUMAN; HYPERBILIRUBINEMIA; LIVER TOXICITY; LIVER VENOOCCLUSIVE DISEASE; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PREDICTIVE VALUE; PRIORITY JOURNAL; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL (TOPIC); RECEIVER OPERATING CHARACTERISTIC; RELAPSE; RETROSPECTIVE STUDY; RISK ASSESSMENT; SEATTLE CRITERIA; SENSITIVITY AND SPECIFICITY; SURGICAL MORTALITY; SURVIVAL PREDICTION; VEIN OCCLUSION;

ADOLESCENT; ADULT; AGED; ALGORITHMS; ALKALINE PHOSPHATASE; BILIRUBIN; EARLY DIAGNOSIS; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEPATIC VENO-OCCLUSIVE DISEASE; HUMANS; HYPERBILIRUBINEMIA; INCIDENCE; JAPAN; LIVER; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TRANSPLANTATION, HOMOLOGOUS; YOUNG ADULT;

EID: 84872133686     PISSN: 02683369     EISSN: 14765365     Source Type: Journal    
DOI: 10.1038/bmt.2012.130     Document Type: Article

References (15)

1. McDonald GB. Hepatobiliary complications of hematopoietic cell transplantation, 40 years on. Hepatology 2010; 51: 1450-1460.
2. Bearman SI. The syndrome of hepatic veno-occlusive disease after marrow transplantation. Blood 1995; 85: 3005-3020.
3. McDonald GB, Sharma P, Matthews DE, Shulman HM, Thomas ED. Venocclusive disease of the liver after bone marrow transplantation: diagnosis, incidence, and predisposing factors. Hepatology 1984; 4: 116-122. (Pubitemid 14185436)
4. Jones RJ, Lee KS, Beschorner WE, Vogel VG, Grochow LB, Braine HG et al. Venoocclusive disease of the liver following bone marrow transplantation. Transplantation 1987; 44: 778-783. (Pubitemid 18034278)
5. Carreras E, Bertz H, Arcese W, Vernant JP, Tomas JF, Hagglund H et al. Incidence and outcome of hepatic veno-occlusive disease after blood or marrow transplantation: a prospective cohort study of the European Group for Blood and Marrow Transplantation. European Group for Blood and Marrow Transplantation Chronic Leukemia Working Party. Blood 1998; 92: 3599-3604. (Pubitemid 28525185)
6. McDonald GB, Hinds MS, Fisher LD, Schoch HG, Wolford JL, Banaji M et al. Venoocclusive disease of the liver and multiorgan failure after bone marrow transplantation: a cohort study of 355 patients. Ann Intern Med 1993; 118: 255-267. (Pubitemid 23046384)
7. Hagglund H, Remberger M, Klaesson S, Lonnqvist B, Ljungman P, Ringden O. Norethisterone treatment, a major risk-factor for veno-occlusive disease in the liver after allogeneic bone marrow transplantation. Blood 1998; 92: 4568-4572. (Pubitemid 29005858)
8. Coppell JA, Richardson PG, Soiffer R, Martin PL, Kernan NA, Chen A et al. Hepatic veno-occlusive disease following stem cell transplantation: incidence, clinical course, and outcome. Biol Blood Marrow Transplant 2010; 16: 157-168.
9. Atkinson K, Biggs J, Dodds A, Concannon A. Cyclosporine-associated hepatotoxicity after allogeneic marrow transplantation in man: differentiation from other causes of posttransplant liver disease. Transplant Proc 1983; 15: 2761-2767. (Pubitemid 14158753)
10. Ogawa N, Kanda Y, Matsubara M, Asano Y, Nakagawa M, Sakata-Yanagimoto M et al. Increased incidence of acute graft-versus-host disease with the continuous infusion of cyclosporine A compared to twice-daily infusion. Bone Marrow Transplant 2004; 33: 549-552. (Pubitemid 38425787)
11. Oshima K, Sato M, Terasako K, Kimura S, Okuda S, Kako S et al. Target blood concentrations of CYA and tacrolimus in randomized controlled trials for the prevention of acute GVHD after hematopoietic SCT. Bone Marrow Transplant 2010; 45: 781-782.
12. Gray RJ. A class of k-sample tests for comparing the cumulative incidence of a competing risk. Ann Stat 1988; 16: 1141-1154.
13. Kanda Y. Free statistical software: EZR (Easy R) on R commander. (Accessed 1 March 2012, at http://www.jichi.ac.jp/saitama-sct/SaitamaHP.files/ statmedEN. html.).
14. Lassau N, Auperin A, Leclere J, Bennaceur A, Valteau-Couanet D, Hartmann O. Prognostic value of Doppler-ultrasonography in hepatic veno-occlusive disease. Transplantation 2002; 74: 60-66. (Pubitemid 34779212)
15. van den Bosch MA, van Hoe L. MR imaging findings in two patients with hepatic veno-occlusive disease following bone marrow transplantation. Eur Radiol 2000; 10: 1290-1293.